HIGHLIGHTS
- who: Longjiang She from the Sun Yat-sen University Center (SYSUCC), China have published the article: Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma, in the Journal: (JOURNAL)
- what: The aim of the NCT02958111 trial was to estimate the effect of metronomic capecitabine treatment for one year.
- how: Since the clinical trial was conducted in China the authors analyzed the results from the perspective of China as well. Besides the authors developed structural sensitive analysis to estimate the costeffectiveness of metronomic capecitabine for three years. The results . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.